Skip to content

On the plains of Africa you’ll find a surprising cooperation between two typically adversarial animals—the drongo bird and the meerkat. What makes the relationship especially vexing is that they both covet the same food. But instead of being fierce adversaries, they maintain a symbiotic partnership. When predators to the meerkat are in the vicinity, the drongo bird will give out a warning cry, alerting the spirited mammals of the danger. The meerkats quickly scurry back to their burrows, and in their haste often drop a bit of food. The drongo swoops in and grabs the free meal, while the meerkat huddles in his hole avoiding the predator. A win-win.  

In a similar manner (albeit generally not on the plains of Africa), the relationship between broadly syndicated loans (BSL) and direct lending (DL) could be considered more symbiotic than adversarial as well. While in recent months the media has presented it as an either-or situation, with headlines like “Private credit’s golden era may face strain amid a resurgence in the BSL market,”1 it is not necessarily so binary. In many instances borrowers can have their BSL cake and eat DL as well.

Increased deal flow—a win for credit investors

As banks increase their risk appetite, which they have in recent months given the strong macroeconomic backdrop, they will start putting more capital into the market in the form of BSL commitments. This bank action in some ways acts as a lubricant for the merger-and-acquisition (M&A) machine. The animal spirits come back and the pie grows. While DL may lose some share of the market to BSL as a result, in my experience there are enough deals with enough spread to keep both the drongo fat and the meerkat happy (Exhibit 1).

Exhibit 1: The Deal Pie Is Bigger

New-Issue Volume for Deals Financing LBOs
Data through March 18, 2024

Source: PitchBook | LCD • Data through March 18, 2024.
Direct lending analysis is based on transactions covered by LCD News

Any competition between BSL and DL, when it does occur, tends to happen in the upper middle market—companies with EBITDA2 >US$100 million. Direct lenders in that portion of the market may lose some market share and see spreads compressed. However, the core middle market—companies with EBITDA between US$25 million-US$100 million—will still benefit from increased deal flow, as financial sponsors (the lifeblood of this segment) get more comfortable doing deals after a period of dormancy. It is still a win-win. Business media outlets like Bloomberg and others tend to underreport these middle-market transactions, because they lack the sensational value of a US$1 billion+ headline. These under the radar transactions are where alpha may be captured. For example, the core middle market still has a healthy, albeit diminished, illiquidity premium. In contrast, the upper middle market has seen its illiquidity premium over syndicated deals get squeezed significantly.

The bottom line is that it doesn’t have to be a binary selection between BSL or DL debt for allocators—there are opportunities in both. We see in Exhibit 2 that private credit deals continued to grow in number over the first quarter of 2024.     

Exhibit 2: Direct Lending Is not Going Away

Count of LBOs Financed in BSL vs. Private Credit Market
Data through March 18, 2024

 

Source: Source: PitchBook | LCD • Data through March 18, 2024
Private credit count is based on transactions covered by LCD News

The symbiotic relationship between BSL and DL is even more direct in some situations. More recently we are seeing deals that have both a BSL and DL structure. For example, in February of this year Ardonaugh Group Ltd.3 recapitalized its business with both DL and BSL components in the financing.

This practice isn’t abnormal. For many years, the typical LBO would have a first lien BSL component provided by collateralized loan obligations (CLOs), and a junior second-lien component provided by direct lending firms. Eventually lines got blurred and these structures became blended unitranche deals, where everyone was competing for the same pie. Today we're seeing a return of second-lien deals, such as the financing to support the leveraged buyout of Truist Financial Corp.’s insurance business.4 In my view, this practice is a better way of slicing the pie—the risk gets allocated appropriately. Those who want lower risk (BSL lenders) get the lower risk senior debt (first lien), and those seeking higher spread get the second-lien junior debt.  

Not always win-win: Covenant-lite growth may be warning sign

While both BSL and DL can coexist in the same market, there can be a downside to increased competition between the two debt structures. When markets get more competitive in the upper- middle-market segment, we often begin to see more risk-taking. Symptoms of froth, such as a lack of financial maintenance covenants (cov-lite) in documents, may become more frequent in DL structures. This should be the exception not the norm. This heightened risk can spread to the core middle market as well, which is not fully immune from these trends despite being more sheltered from competition. 

In conclusion, increased activity in the BSL space is not necessarily a bad thing for DL, and vice versa. They can coexist and even complement each other, providing a variety of financing options for different risk appetites. It is not an either/or condition, it is both/and. Even birds and cats get along sometimes.



Copyright ©2025. Franklin Templeton. All rights reserved.

This document is intended to be of general interest only. This document should not be construed as individual investment advice or offer or solicitation to buy, sell or hold any shares of fund. The information provided for any individual security mentioned is not a sufficient basis upon which to make an investment decision. Investments involves risks. Value of investments may go up as well as down and past performance is not an indicator or a guarantee of future performance. The investment returns are calculated on NAV to NAV basis, taking into account of reinvestments and capital gain or loss. The investment returns are denominated in stated currency, which may be a foreign currency other than USD and HKD (“other foreign currency”). US/HK dollar-based investors are therefore exposed to fluctuations in the US/HK dollar / other foreign currency exchange rate. Please refer to the offering documents for further details, including the risk factors.

The data, comments, opinions, estimates and other information contained herein may be subject to change without notice. There is no guarantee that an investment product will meet its objective and any forecasts expressed will be realized. Performance may also be affected by currency fluctuations. Reduced liquidity may have a negative impact on the price of the assets. Currency fluctuations may affect the value of overseas investments. Where an investment product invests in emerging markets, the risks can be greater than in developed markets. Where an investment product invests in derivative instruments, this entails specific risks that may increase the risk profile of the investment product. Where an investment product invests in a specific sector or geographical area, the returns may be more volatile than a more diversified investment product. Franklin Templeton accepts no liability whatsoever for any direct or indirect consequential loss arising from use of this document or any comment, opinion or estimate herein. This document may not be reproduced, distributed or published without prior written permission from Franklin Templeton.

Any share class with “(Hedged)” in its name will attempt to hedge the currency risk between the base currency of the Fund and the currency of the share class, although there can be no guarantee that it will be successful in doing so. In some cases, investors may be subject to additional risks.

Please contact your financial advisor if you are in doubt of any information contained herein.

For UCITS funds only: In addition, a summary of investor rights is available from here. The fund(s)/ sub-fund(s) are notified for marketing in various regions under the UCITS Directive. The fund(s)/ sub-fund(s) can terminate such notifications for any share class and/or sub-fund at any time by using the process contained in Article 93a of the UCITS Directive.

For AIFMD funds only: In addition, a summary of investor rights is available from here. The fund(s)/ sub-fund(s) are notified for marketing in various regions under the AIFMD Directive. The fund(s)/ sub-fund(s) can terminate such notifications for any share class and/or sub-fund at any time by using the process contained in Article 32a of the AIFMD Directive.

For the avoidance of doubt, if you make a decision to invest, you will be buying units/shares in the fund(s)/ sub-fund(s) and will not be investing directly in the underlying assets of the fund(s)/ sub-fund(s).

This document is issued by Franklin Templeton Investments (Asia) Limited and has not been reviewed by the Securities and Futures Commission of Hong Kong.

Unless stated otherwise, all information is as of the date stated above. Source: Franklin Templeton.

CFA® and Chartered Financial Analyst® are trademarks owned by CFA Institute.